Cargando…

O17 - Assessment of efficacy and safety of sublingual tablets of house dust mite allergen extract in children and adolescents with allergic rhinitis

Detalles Bibliográficos
Autores principales:	Halken, Susanne, Wahn, Ulrich, Mélac, Michel, Nguyen, Hélène, Cadic, Véronique, Zeldin, Robert K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082074/ http://dx.doi.org/10.1186/2045-7022-4-S1-O17

Ejemplares similares

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children
por: Lim, Jae Hyun, et al.
Publicado: (2017)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets
por: Vitiello, Gianfranco, et al.
Publicado: (2020)

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
por: Worm, Margitta, et al.
Publicado: (2014)

Exposure to House Dust Mite Allergen and Endotoxin in Early Life and Sensitization and Allergic Rhinitis: The JECS
por: Kojima, Reiji, et al.
Publicado: (2022)

Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites
por: Kim, Shin Hye, et al.
Publicado: (2015)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy
por: Aarestrup, Matheus Fonseca, et al.
Publicado: (2021)

Regulation of Constitutive Neutrophil Apoptosis Due to House Dust Mite Allergen in Normal and Allergic Rhinitis Subjects
por: Kim, Eun Hye, et al.
Publicado: (2014)

Validated allergen exposure chamber is plausible tool for the assessment of house dust mite‐triggered allergic rhinitis
por: Zemelka‐Wiacek, Magdalena, et al.
Publicado: (2022)

Allergic rhinitis behavioral changes after Indonesian house dust mites allergenic extract administration as immunotherapy
por: Pratama, Yusuf Alif, et al.
Publicado: (2023)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials
por: Feng, Bohai, et al.
Publicado: (2017)

Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite–Induced Allergic Rhinitis
por: Xie, Shaobing, et al.
Publicado: (2021)

Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites
por: Kim, Ji Hye, et al.
Publicado: (2018)

Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population
por: Okamoto, Yoshitaka, et al.
Publicado: (2018)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
por: Mösges, Ralph, et al.
Publicado: (2021)

Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis
por: Kim, Sang Hoon, et al.
Publicado: (2014)

A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
por: Lee, Ji-Ho, et al.
Publicado: (2018)

Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients
por: Huang, Yanran, et al.
Publicado: (2019)

House Dust Mite and Grass Pollen Allergen Extracts for Seasonal Allergic Rhinitis Treatment: A Systematic Review
por: Sialakis, Christos, et al.
Publicado: (2022)

Prevalence and Clinical Characteristics of Local Allergic Rhinitis to House Dust Mites
por: Jung, Chang-Gyu, et al.
Publicado: (2017)

Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis
por: Ma, Yun, et al.
Publicado: (2020)

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients
por: Hüser, C., et al.
Publicado: (2016)

Erratum: In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2017)

Cost-effectiveness of SQ(®) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany
por: Green, William, et al.
Publicado: (2017)

The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018)

TSLP receptor is not essential for house dust mite-induced allergic rhinitis in mice
por: Nakanishi, Wakako, et al.
Publicado: (2016)

Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?
por: Muntean, Ioana Adriana, et al.
Publicado: (2020)

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3p9dhkc8sr29h1o0vn14bdivt